Hoya ConBio/Cynosure RevLite
Q-Switched Tattoo/Pigment · QS Nd:YAG multi-wavelength PTP
Technology: Nd:YAG Laser
Classification & configurations
Category group: Resurfacing & pigment (ablative, fractional, picosecond, vascular)
At a glance
- New-unit reference · older model
- Not published
- Used asking price
- $15k–$28kSource not documented
- FDA status
- Supplies & recurring costs
- Supply details not yet documented.
Sources and verified data on file
Data on file
- Recurring consumables
- Not verified
- Used asking prices
- Not verified
- This panel shows a per-treatment supply cost only when a recorded figure has a dated source.
- Bottle prices and estimates may still appear under Treatment & running costs.
- The calculator may include a labeled planning estimate. Review it or enter your own allowance; missing data never means $0.
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Read FDA-cleared indicationsExact wording from 5 FDA records
K133254 (Cynosure, Inc., 2014)
RevLite Q-Switched Nd:YAG Laser System. Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific indications: 1064 nm wavelength: • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions; including, but not limited to: Nevus of Ota, Lentigines, Nevi, Melasma and Cafe-au-lait • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm Wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions; including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus, seborrheic keratosis • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K103118 (Hoya Photonics, Inc., 2010)
Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K083899 (Hoya Conbio, Inc., 2009)
Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K063834 (Hoya Conbio, Inc., 2007)
The RevLite Q-switched Nd: YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications 1064 nm wavelength: Tattoo Removal: Dark Ink: (Black & Blue) Nevus of Ota Removal or lightening of unwanted hair with or without adjuvant preparation. Skin resurfacing procedures for the treatment of acne scars and wrinkles 532 nm wavelength (nominal delivered energy of 585nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green) Treatment of Vascular Lesions including, but not limited to: * Prot wine birthmarks * Telangiectasias * Spider angionma * Cherry angioma * Spider nevi Treatment of Pigmented Lesions including, but not limited to: * Caf6-au-lait bithmarks * Solar lentiginos * Senile lentiginos * Becker's nevi * Freckles * Nevus spilus Skin resurfacing procedures for the treatment of acne scars and wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K063112 (Hoya Conbio, Inc., 2006)
The RevLite Q-Switched Nd:YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength: Tattoo Removal: Dark Ink (Black & Blue); Nevus of Ota; Removal or lightening of unwanted hair with or without adjuvant preparation; Skin resurfacing procedures for the treatment of acne scars and wrinkles. 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green); Treatment of Vascular Lesions including, but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi; Treatment of Pigmented Lesions including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, freckles, nevus spilus; Skin resurfacing procedures for the treatment of acne scars and wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 8, 2026 · How we verify
No new-unit price reference is published for this older model.
Axis runs $0–$28k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
Price sourcesSources, dates and configurations
Key factsCompany, specifications and verification dates
| Manufacturer | Hoya ConBio/Cynosure |
|---|---|
| Company | Not published |
| Parent company | Cynosure Lutronic |
| Brand owner | Hoya ConBio/Cynosure |
| Built by (OEM) | Hoya ConBio |
| Category | Q-Switched Tattoo/Pigment |
| Technology | QS Nd:YAG multi-wavelength PTP |
| FDA status | FDA Cleared |
| 510(k) citation | K133254, K103118, K083899, K063834, K063112 |
| New-unit reference (older model) | Not published |
| Used asking range | $15k–$28k |
| Consumables | Not published |
| Launch year | 2009 |
| Pricing | Not published |
| Manufacturer-source documents checked | Not published |
Overview
Higher-energy successor to C6
FDA & regulatory detailClearance timeline, authorization route and citation notes
510(k): K133254 (RevLite Q-switched Nd:YAG laser system, Cynosure, decision 5 Mar 2014), with earlier clearances K103118 (Hoya Photonics, 19 Nov 2010), K083899 (Hoya ConBio, 1 Jun 2009), K063834 (RevLite C6, 25 Jan 2007) and K063112 (1 Dec 2006). Checked 8 Sep 2026.
FDA-cleared indications (verbatim)
K133254 (Cynosure, Inc., 2014)
RevLite Q-Switched Nd:YAG Laser System. Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific indications: 1064 nm wavelength: • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions; including, but not limited to: Nevus of Ota, Lentigines, Nevi, Melasma and Cafe-au-lait • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm Wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions; including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus, seborrheic keratosis • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions; including, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K103118 (Hoya Photonics, Inc., 2010)
Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Dermal Pigmented Lesions • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength)
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K083899 (Hoya Conbio, Inc., 2009)
Intended Use: Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength • Tattoo Removal (dark ink: blue and black) • Nevus of Ota • Removal or lightening of hair with or without adjuvant preparation • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength). 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece) • Tattoo removal (light ink: red, sky blue, green) • Vascular lesions including but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi • Epidermal Pigmented lesions including but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, Freckles, Nevus spilus • Skin Resurfacing for Acne Scars and Wrinkles • Benign cutaneous lesions, such as, but not limited to: striae and scars (excludes the 650nm wavelength) • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar (excludes the 650nm wavelength).
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K063834 (Hoya Conbio, Inc., 2007)
The RevLite Q-switched Nd: YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications 1064 nm wavelength: Tattoo Removal: Dark Ink: (Black & Blue) Nevus of Ota Removal or lightening of unwanted hair with or without adjuvant preparation. Skin resurfacing procedures for the treatment of acne scars and wrinkles 532 nm wavelength (nominal delivered energy of 585nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green) Treatment of Vascular Lesions including, but not limited to: * Prot wine birthmarks * Telangiectasias * Spider angionma * Cherry angioma * Spider nevi Treatment of Pigmented Lesions including, but not limited to: * Caf6-au-lait bithmarks * Solar lentiginos * Senile lentiginos * Becker's nevi * Freckles * Nevus spilus Skin resurfacing procedures for the treatment of acne scars and wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K063112 (Hoya Conbio, Inc., 2006)
The RevLite Q-Switched Nd:YAG Laser System is indicated for Incision, Excision, Ablation, Vaporization of Soft Tissue for General Dermatology, Dermatologic and General Surgical Procedures for Coagulation and Hemostasis. Specific Indications: 1064 nm wavelength: Tattoo Removal: Dark Ink (Black & Blue); Nevus of Ota; Removal or lightening of unwanted hair with or without adjuvant preparation; Skin resurfacing procedures for the treatment of acne scars and wrinkles. 532 nm wavelength (nominal delivered energy of 585 nm and 650 nm with the Optional Multilite Dye Laser Handpiece): Tattoo Removal: Light Ink (Red, Sky Blue, Green); Treatment of Vascular Lesions including, but not limited to: port wine birthmarks, telangiectasias, spider angioma, cherry angioma, spider nevi; Treatment of Pigmented Lesions including, but not limited to: cafe-au-lait birthmarks, solar lentigines, senile lentigines, Becker's nevi, freckles, nevus spilus; Skin resurfacing procedures for the treatment of acne scars and wrinkles.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
Nd:YAG — QS Nd:YAG multi-wavelength PTP
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: Cynosure Lutronic
Legal manufacturer: Hoya ConBio (United States)
Applicant on the FDA record
Cynosure, Inc.The applicant named on the FDA record can differ from the brand shown on the device.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Treatment & running costs
Treatments
Sessions & timing
No treatment schedule documented yet.
What practices charge
No sourced treatment price on file.
Supplies & recurring costs
Consumable costs are not documented yet.
Annual service & support
No annual service cost documented yet.
Payback calculatorModel your own volume, labor and service costs
Estimate your payback
Pre-filled from our published Hoya ConBio/Cynosure RevLite data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published used asking range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Your estimate
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Warranty & serviceWhat to confirm in writing before you buy
Before buying new or used, confirm in writing:
- Current warranty coverage
- Included training
- Service terms
Chains using this device
A chain listing does not establish availability at every location.
No confirmed chain deployments recorded yet.
Owner & operator reviews
Write a reviewNo owner or operator reviews yet. Be the first →
Current alternatives
Current catalog models to research. Confirm availability and configuration with the supplier.
History4 tracked changes
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 8, 2026
FDA status
Unknown → Cleared
Source: Record correction
September 8, 2026
FDA K-numbers
K133254; K103118; K083899; K063834; K063112
Source: Record correction
September 8, 2026
FDA source URL
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K133254
Source: Record correction
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "Hoya ConBio/Cynosure RevLite — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.
Browse current modelsDevice and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.